Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07067112 SIIM-reg — Suppressive Functions of Regulatory T Cells in Migraine |
Blood sampling, questionnaire and… | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU Clermont-Ferrand, Clermont-Ferrand, Fran… | 2026-07-01 → 2027-11-30 | Ouvrir |
| NCT02090998 Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transfo… |
SPG Block with 5% Lidocaine gel | Migraine | Phase 4 | TERMINATED | En attente / non publié | Rutgers, The State University of … | United States · Rutgers, Robert Wood Johnson Medical … | 2014-05 → 2020-03-16 | Ouvrir |
| NCT07018713 MINT-C — A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® In… |
Xeomin | Migraine | Phase 3 | RECRUITING | En attente / non publié | Merz Therapeutics GmbH | United States, Austria, Canada, Czechia, Denmark, Fra… | 2025-08-21 → 2028-03 | Ouvrir |
| NCT05748483 ATO-TOPIRAMATE — Comparative Study of Oral Atogepant Versus Oral Topira… |
Atogepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | AbbVie | Austria, Belgium, Canada, Czechia, France, Germany, H… | 2023-10-07 → 2026-06-02 | Ouvrir |
| NCT07690215 PRACTICE — Study to Assess Effectiveness of Oral Atogepant in Adult Par… |
PRACTICE — Study to Assess Effect… | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | AbbVie | Non communiqué | 2026-09-01 → 2028-03 | Ouvrir |
| NCT07691164 CEREB — Evolution of the Cognitive Profile and Quality of Life of Adult… |
CEREB — Evolution of the Cognitiv… | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Strasbourg, … | France · Hopitaux Universitaires de Strasbourg, Stras… | 2026-10-01 → 2029-09-30 | Ouvrir |
| NCT05858801 SalviaBio — First Evaluation of a Craniofacial Nerve Stimulation System… |
PRIMUS | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Salvia BioElectronics | Belgium · AZ Delta, Roeselare, Belgium | 2023-05-09 → 2027-12-31 | Ouvrir |
| NCT06810505 A Study of Oral Atogepant Tablets to Assess Adverse Events and Change i… |
Atogepant | Migraine | Phase 3 | RECRUITING | En attente / non publié | AbbVie | United States, Canada, Denmark, Hungary, Italy, Japan… | 2025-02-13 → 2031-03 | Ouvrir |
| NCT07500558 Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Ve… |
Standarad PRF | Migraine | Non applicable | RECRUITING | En attente / non publié | Minia University | Egypt · Minia university raouf, Minya, Egypt | Minia … | 2026-03-31 → 2027-04-02 | Ouvrir |
| NCT06735833 MMA Embolization for Refractory Chronic Migraine |
Middle Meningeal Artery embolizat… | Migraine | Non applicable | RECRUITING | En attente / non publié | The Affiliated Hospital Of Guizho… | United States · Barrow Neurological Institute at St. … | 2025-04-23 → 2029-07-31 | Ouvrir |
| NCT04965675 PROSPECT-2 — A Study With Eptinezumab in Adolescents (12-17 Years) With… |
Eptinezumab | Migraine | Phase 3 | RECRUITING | En attente / non publié | H. Lundbeck A/S | United States, Argentina, Canada, Italy, Mexico, Pola… | 2021-06-30 → 2026-10-31 | Ouvrir |
| NCT06158737 A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic… |
JS010 injection | Migraine | Phase 1 | COMPLETED | En attente / non publié | Shanghai Junshi Bioscience Co., L… | China · Peking University Third Hospital, Beijing, Ch… | 2023-05-10 → 2024-06-23 | Ouvrir |
| NCT07698249 Headache Diary for Migraine Patients |
Headache Diary for Migraine Patie… | Migraine | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Hackensack Meridian Health | United States · Hackensack Meridian Health - JFK Medi… | 2025-01-14 → 2029-08-01 | Ouvrir |
| NCT05576467 TEAM-M — Treatment for Migraine and Mood |
TEAM-M — Treatment for Migraine a… | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Amanda Shallcross | United States · Albert Einstein College of Medicine, … | 2024-03-17 → 2026-10-20 | Ouvrir |
| NCT06485336 Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicS… |
Atorvastatin 40mg | Migraine | Phase 2 | RECRUITING | En attente / non publié | St. Olavs Hospital | Norway · Haukeland University Hospital, Bergen, Norwa… | 2024-05-01 → 2029-02-28 | Ouvrir |
| NCT05598723 BOTOX® vs. XEOMIN® for Chronic Migraine |
IncobotulinumtoxinA (XEOMIN®) | Migraine | Phase 3 | RECRUITING | En attente / non publié | Naval Medical Center Camp Lejeune | United States · Naval Medical Center Camp Lejeune, Ja… | 2023-02-24 → 2027-08-24 | Ouvrir |
| NCT07720895 Does not exist — Default Mode Network Connectivity and Nocebo Responses… |
Does not exist — Default Mode Net… | Migraine | Non applicable | COMPLETED | En attente / non publié | Ioanna Spanou | Greece · 1st Neurogy Department, Aeginition Hospital,… | 2019-10-22 → 2023-10-22 | Ouvrir |
| NCT07720765 Optical Coherence Tomography in Neurological Practice: Utility and Appl… |
Optical Coherence Tomography (OCT… | Migraine | À vérifier | RECRUITING | En attente / non publié | IRCCS San Raffaele | Italy · IRCCS Ospedale San Raffaele - Neurology and N… | 2023-10-09 → 2031-04-01 | Ouvrir |
| NCT06603558 Atogepant PMSS — Post-Marketing Study to Assess the Safety and Effectiv… |
Atogepant | Migraine | À vérifier | RECRUITING | En attente / non publié | AbbVie | South Korea · Ajou University Hospital - Suwon-si /ID… | 2024-09-24 → 2029-05 | Ouvrir |
| NCT07297901 App-based Breathing Program for Migraine Relief |
App-based Breathing Program for M… | Migraine | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Arizona State University | United States · Arizona State University, Phoenix, Un… | 2025-12-15 → 2026-09-30 | Ouvrir |
| NCT04530110 A Trial to Test if Fremanezumab is Effective in Preventing Migraine in … |
Fremanezumab | Migraine | Phase 3 | COMPLETED | En attente / non publié | Teva Branded Pharmaceutical Produ… | United States, Canada, Finland, Germany, Israel, Ital… | 2020-09-16 → 2025-12-22 | Ouvrir |
| NCT03539393 Fremanezumab Managed Access Program for Pediatric Patients |
Fremanezumab | Migraine | À vérifier | AVAILABLE | En attente / non publié | Teva Branded Pharmaceutical Produ… | Non communiqué | Non communiqué | Ouvrir |
| NCT07292090 Yogabased Movements for Primary Headaches (Migraine and/or Cluster Head… |
Yogabased Movements for Primary H… | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Karolinska Institutet | Sweden · Karolinska Institutet, Huddinge, Sweden | 2026-01-01 → 2026-12-30 | Ouvrir |
| NCT07425041 EDLMMG — Effectiveness of Manual Lymphatic Drainage in the Physiotherap… |
EDLMMG — Effectiveness of Manual … | Migraine | Non applicable | COMPLETED | En attente / non publié | Camilo Jose Cela University | Spain · University Camilo José Cela, Madrid, Spain | 2026-03-20 → 2026-07-01 | Ouvrir |
| NCT04936321 I-SPY-RCT — Intervention for Sleep and Pain in Youth: A Randomized Cont… |
I-SPY-RCT — Intervention for Slee… | Migraine | Non applicable | COMPLETED | En attente / non publié | Seattle Children's Hospital | United States · Seattle Children's Hospital, Seattle,… | 2021-10-01 → 2026-05-06 | Ouvrir |